The pharmaceutical industry is criticizing the Trump administration’s plan for carrying out a critical round of Biden-era ...

A new fight is brewing over the Medicare drug price negotiation program after the Trump administration proposed to consider ...

A provision protecting expensive medications, used to treat multiple rare diseases, from the Medicare drug price negotiations made its way back ... for drugs designed to treat just one rare disease.

The sweeping One Big Beautiful Bill Act, signed into federal law July 4, amended CMS’ drug price negotiations authority that could absolve nearly $5 billion in projected savings, according to the ...

A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news ...

Medicare drug price negotiation is still relatively new. Until the 2022 passage of the Inflation Reduction Act, Medicare part D, which covers more than 50 million seniors , didn't have the ...

Medicare inflation rebates fail to curb rising drug prices, highlighting the need for further policy action to control costs.

The Department of Health and Human Services has said it expects drugmakers in the U.S. to set prices for their products at the lowest price paid by other high-income countries.

MORE: Medicare recipients say new drug price negotiations will save them thousands. START HERE: And these are, like you said, like the 10 most-used drugs in the Medicare system.

Guidelines aimed at increasing transparency about how the regulator will evaluate pharmaceutical pricing, official says ...